Draxis and Isotope Products Laboratories sign distribution agreement
Draximage Inc. will market the full line of Isotope Products Laboratories' (IPL) radioactive sources for nuclear medicine and radiography in Canada.

Draximage also will market the California-based company's calibration references for imaging applications and calibration sources for PET (positron emission tomography) and SPECT (single photon emission computed tomography) and introduce IPL's new flexible Cobalt-57 flood source, Perflexion, in Canada during the second quarter.

Draximage, based in Mississauga, Ontario, Canada, is the radiopharmaceutical subsidiary of Draxis Health Inc.

IPL operates two manufacturing facilities employing professional staff, primarily chemists and engineers, and sells its products in more than 30 countries around the world.